真鍋責任著者

Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2.

2024.03.30

Yoshiyuki Manabe,* B. Gárate-Reyes, K. Ito, R. Hurtado-Guerrero, Kazuya Kabayama, and Koichi Fukase*
Chem. Commun. 2024, in press.